Home Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
Article
Licensed
Unlicensed Requires Authentication

Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay

  • Ruchi Nadar , Nikhil Phadke , Kavita Khatod , Vaman Khadilkar and Anuradha V. Khadilkar EMAIL logo
Published/Copyright: May 22, 2014

Abstract

Background: Life threatening conditions are associated with atypical genitalia in newborns. Analysis of genetic sex provides a clue to the underlying etiology in newborns with disorders of sex development (DSD) and can guide further endocrine investigations. Rapid diagnosis of genetic sex would be immensely useful in this situation. Traditionally used methods such as karyotype and fluorescence in situ hybridisation are time-consuming.

Objectives: To study the clinical applicability of an indigenously developed rapid real-time polymerase chain reaction (RT-PCR) assay for the sex determining region on the Y chromosome (SRY gene) and the DYS14 locus in newborns with DSD.

Methods: Clinical examination, endocrinological tests, RT-PCR analysis of SRY and DYS14 and karyotype was performed in 15 newborns with DSD.

Results: Results of PCR were available within 4 h. Based on this report, in SRY/DYS14 positive cases, further tests for assessment of testicular function were done. In SRY negative cases, tests for congenital adrenal hyperplasia were done. On comparing PCR results with other tests, the Y chromosome was present on karyotype and testicular tissue was detected by endocrinological and/or histological methods in all (8/15) SRY positive cases. The SRY and DYS14 negative cases (7/15) did not have Y chromosome in the karyotype. Congenital adrenal hyperplasia (CAH) was the most common diagnosis in this group.

Conclusions: The indigenously developed PCR for dual Y chromosome markers is rapid and sensitive. Further endocrine evaluation of newborns with DSD can be based on these results. Information of genetic sex partly allays the psychosocial distress associated with the condition.


Corresponding author: Dr. Anuradha V. Khadilkar, MD, Associate Professor, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, India, Phone: +91 20 26141340, Fax: +91 20 26141340, E-mail:

References

1. Kliegman RM, Stanton BF, St. Jemell JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics, 19th ed. Philadelphia, PA: Saunders, 2011.Search in Google Scholar

2. Crissman HP, Warner L, Gardner M, Carr M, Schast A, et al. Children with disorders of sex development: a qualitative study of early parental experience. Int J Pediatr Endocrinol 2011;2011:10.10.1186/1687-9856-2011-10Search in Google Scholar PubMed PubMed Central

3. Ogilvy-Stuart AL, Brain CE. Early assessment of ambiguous genitalia. Arch Dis Child 2004;89:401–7.10.1136/adc.2002.011312Search in Google Scholar PubMed PubMed Central

4. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598–604.10.1373/clinchem.2005.051235Search in Google Scholar PubMed

5. Huges IA. Ambiguous genitalia. In: Brook C, Clayton P, Brown R editors. Brooks clinical pediatric endocrinology, 5th ed. Oxford, UK: Blackwell Publishing Ltd, 2005.Search in Google Scholar

6. Lee PA, Houk CP, Ahmed SF, Hughes IA. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006;118:e488–500.10.1542/peds.2006-0738Search in Google Scholar PubMed

7. Scheffer PG, van der Schoot CE, Page-Christiaens GC, Bossers B, van Erp F, et al. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010;115:117–26.10.1097/AOG.0b013e3181c3c938Search in Google Scholar PubMed

8. Kastelic V, Budowle B, Drobnic K. Validation of SRY marker for forensic casework analysis. J Forensic Sci 2009;54:551–5.10.1111/j.1556-4029.2009.01007.xSearch in Google Scholar PubMed

9. Coriat AM, Müller U, Harry JL, Uwanogho D, Sharpe PT. PCR amplification of SRY-related gene sequences reveals evolutionary conservation of the SRY-box motif. PCR Methods Appl 1993;2:218–22.10.1101/gr.2.3.218Search in Google Scholar PubMed

10. Lobaccaro JM, Medlej R, Berta P, Belon C, Galifer RB, et al. PCR analysis and sequencing of the SRY sex determining gene in four patients with bilateral congenital anorchia. Clin Endocrinol (Oxf) 1993;38:197–201.10.1111/j.1365-2265.1993.tb00993.xSearch in Google Scholar PubMed

11. Aslanzadeh J. Preventing PCR amplification carryover contamination in a clinical laboratory. Ann Clin Lab Sci 2004;34:389–96.Search in Google Scholar

12. Erdoğan S, Kara C, Uçaktürk A, Aydın M. Etiological classification and clinical assessment of children and adolescents with disorders of sex development. J Clin Res Pediatr Endocrinol 2011;3:77–83.10.4274/jcrpe.v3i2.16Search in Google Scholar PubMed PubMed Central

13. Bianco B, Lipay M, Guedes A, Oliveira K, Verreschi IT. SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in Turner syndrome. Int J Gynecol Pathol 2009;28:197–202.10.1097/PGP.0b013e318186a825Search in Google Scholar PubMed

14. Sperling MA. Pediatric endocrinology, 3rd ed. Philadelphia, PA: Saunders, 2008:662–81.Search in Google Scholar

15. Hawkins JR. Mutational analysis of SRY in XY females. Hum Mutat 1993;2:347–50.10.1002/humu.1380020504Search in Google Scholar PubMed

16. Vilain EJ. 46,XX Testicular Disorder of Sex Development. 2003 Oct 30 [updated 2009 May 26]. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews™ [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2013. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1416/ PubMed PMID: 20301589.Search in Google Scholar

Received: 2013-10-27
Accepted: 2014-4-7
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Downloaded on 20.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0416/pdf
Scroll to top button